Showing results (31-40 of 140) with videos related to

Sort By:
Pageof 14
Anticancer Research|April 9, 2005
Development of malignant mesothelioma during treatment for prolymphocytic leukemia: is asbestos or simian virus 40 a link?Tawee Tanvetyanon, Amira G Elmishad, Michele Carbone
Clinical Lung Cancer|November 14, 2025
Relationship between PD-L1 Expression and Outcomes of Salvage Treatment Following Durvalumab ConsolidationTawee Tanvetyanon, Dung-Tsa Chen, Jhanelle E Gray
Expert Opinion on Biological Therapy|January 10, 2017
PD-1 checkpoint blockade alone or combined PD-1 and CTLA-4 blockade as immunotherapy for lung cancer?Tawee Tanvetyanon, Jhanelle E Gray, Scott J Antonia
Journal of Clinical Medicine|February 25, 2023
Impact of COVID-19 Pandemic on Frontline Pembrolizumab-Based Treatment for Advanced Lung CancerTawee Tanvetyanon, Dung-Tsa Chen, Jhanelle E Gray
Cancer Control : Journal of the Moffitt Cancer Center|December 21, 2013
Current clinical application of genomic and proteomic profiling in non-small-cell lung cancerTawee Tanvetyanon, Benjamin C Creelan, Alberto A Chiappori
The Annals of Pharmacotherapy|December 31, 2002
Concurrent administration of interferon alfa-2b and beta-1aTawee Tanvetyanon, Edward A Stadtmauer, Lawrence A Kerson
Cancer Treatment and Research Communications|June 5, 2021
Efficacy of tyrosine kinase inhibitors against lung cancer with EGFR exon 18 deletion: Case report and pooled analysisRafael Rubiera-Pebe, James K Hicks, Tawee Tanvetyanon
Clinical Lung Cancer|June 2, 2024
Timeliness of EGFR/ALK Inhibitor Treatment and Survival in Lung Cancer: A Population-Based AnalysisTawee Tanvetyanon, Dung-Tsa Chen, Jhanelle E Gray
Pageof 14